New Key Statistics Module, Z-Score and F-Score
OTCPK:ENTBF Key Ratios
Market Cap $ M | 0.83 |
Enterprise Value $ M | 0.62 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | 4.60 |
Price/Sales | 3.18 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.04 |
Beneish M-Score | 0 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | 21.70 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -2.38 |
EV-to-EBITDA | -2.38 |
PEG | -- |
Shares Outstanding M | 8.86 |
Net Margin (%) | -- |
Operating Margin % | -- |
Pre-tax Margin (%) | -- |
Quick Ratio | 7.86 |
Current Ratio | 7.86 |
ROA % (ttm) | -83.37 |
ROE % (ttm) | -98.26 |
ROIC % (ttm) | -3,520.00 |
Dividend Yield % | -- |
Altman Z-Score | -- |
ENTBF Number of Guru Trades
ENTBF Volume of Guru Trades
Gurus Latest Trades with OTCPK:ENTBF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:ENTBF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Entheon Biomedical Corp Insider Transactions
No Available Data
News about OTCPK:ENTBF
Total 0- 1